Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bufylline
2. Theophylline Aminoisobutanol
1. Bufylline
2. 5634-34-4
3. Butaphyllamine
4. Ambuphylline [usan]
5. Theophylline-2-aminoisobutanol
6. Vou5v0b772
7. Theophylline Compound With 2-amino-2-methyl-1-propanol (1:1)
8. 1h-purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, Compd. With 2-amino-2-methyl-1-propanol (1:1)
9. Ambuphylline (usan)
10. Buthoid
11. 2-amino-2-methylpropan-1-ol;1,3-dimethyl-7h-purine-2,6-dione
12. Theophylline Aminoisobutanol
13. Einecs 227-077-5
14. Unii-vou5v0b772
15. 1-propanol, 2-amino-2-methyl-, Compd. With Theophylline (1:1)
16. Bufylline (ban)
17. Butaphyllamine (tn)
18. Theophylline, Compd. With 2-amino-2-methyl-1-propanol (1:1)
19. Ambuphylline [mi]
20. Bufylline [mart.]
21. 3,7-dihydro-1,3-dimethyl-1h-purine-2,6-dione, Compound With 2-amino-2-methylpropan-1-ol (1:1)
22. Ambuphylline [who-dd]
23. Schembl355316
24. Chembl2104089
25. Dtxsid60204880
26. Akos016340427
27. Db13812
28. Ks-1324
29. Hy-105647
30. Cs-0026398
31. D02884
32. 634t344
33. Q4741993
34. 1,3-dimethyl-1h-purine-2,6(3h,7h)-dione Compound With 2-amino-2-methylpropan-1-ol (1:1)
35. 1,3-dimethyl-2,3,6,7-tetrahydro-1h-purine-2,6-dione; 2-amino-2-methylpropan-1-ol
| Molecular Weight | 269.30 g/mol |
|---|---|
| Molecular Formula | C11H19N5O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Exact Mass | 269.14878949 g/mol |
| Monoisotopic Mass | 269.14878949 g/mol |
| Topological Polar Surface Area | 116 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 310 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
R - Respiratory system
R03 - Drugs for obstructive airway diseases
R03D - Other systemic drugs for obstructive airway diseases
R03DA - Xanthines
R03DA10 - Bufylline
ABOUT THIS PAGE
A Bufylline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bufylline, including repackagers and relabelers. The FDA regulates Bufylline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bufylline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bufylline supplier is an individual or a company that provides Bufylline active pharmaceutical ingredient (API) or Bufylline finished formulations upon request. The Bufylline suppliers may include Bufylline API manufacturers, exporters, distributors and traders.
Bufylline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bufylline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bufylline GMP manufacturer or Bufylline GMP API supplier for your needs.
A Bufylline CoA (Certificate of Analysis) is a formal document that attests to Bufylline's compliance with Bufylline specifications and serves as a tool for batch-level quality control.
Bufylline CoA mostly includes findings from lab analyses of a specific batch. For each Bufylline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bufylline may be tested according to a variety of international standards, such as European Pharmacopoeia (Bufylline EP), Bufylline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bufylline USP).
LOOKING FOR A SUPPLIER?
